Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Pathway and Network Analyses Identify Growth Factor Signaling and MMP9 as Potential Mediators of Mitochondrial Dysfunction in Severe COVID-19

Y. Wang, K. Schughart, TM. Pelaia, T. Chew, K. Kim, T. Karvunidis, B. Knippenberg, S. Teoh, AL. Phu, KR. Short, J. Iredell, I. Thevarajan, J. Audsley, S. Macdonald, J. Burcham, . Predict-Consortium, B. Tang, A. McLean, M. Shojaei

. 2023 ; 24 (3) : . [pub] 20230128

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004493

Grantová podpora
5U19A|100625-07 NIAID NIH HHS - United States

Patients with preexisting metabolic disorders such as diabetes are at a higher risk of developing severe coronavirus disease 2019 (COVID-19). Mitochondrion, the very organelle that controls cellular metabolism, holds the key to understanding disease progression at the cellular level. Our current study aimed to understand how cellular metabolism contributes to COVID-19 outcomes. Metacore pathway enrichment analyses on differentially expressed genes (encoded by both mitochondrial and nuclear deoxyribonucleic acid (DNA)) involved in cellular metabolism, regulation of mitochondrial respiration and organization, and apoptosis, was performed on RNA sequencing (RNASeq) data from blood samples collected from healthy controls and patients with mild/moderate or severe COVID-19. Genes from the enriched pathways were analyzed by network analysis to uncover interactions among them and up- or downstream genes within each pathway. Compared to the mild/moderate COVID-19, the upregulation of a myriad of growth factor and cell cycle signaling pathways, with concomitant downregulation of interferon signaling pathways, were observed in the severe group. Matrix metallopeptidase 9 (MMP9) was found in five of the top 10 upregulated pathways, indicating its potential as therapeutic target against COVID-19. In summary, our data demonstrates aberrant activation of endocrine signaling in severe COVID-19, and its implication in immune and metabolic dysfunction.

Centre for Clinical Research in Emergency Medicine Harry Perkins Institute of Medical Research Royal Perth Hospital Perth WA 6000 Australia

Centre for Clinical Research in Emergency Medicine Royal Perth Bentley Group Perth WA 6000 Australia

Centre for Immunology and Allergy Research The Westmead Institute for Medical Research Sydney NSW 2145 Australia

Centre for Infectious Diseases and Microbiology The Westmead Institute for Medical Research Sydney NSW 2145 Australia

Department of Infectious Diseases The University of Melbourne at the Peter Doherty Institute for Infection and Immunity Melbourne VIC 3000 Australia

Department of Intensive Care Medicine Nepean Hospital Kingswood NSW 2747 Australia

Department of Microbiology Immunology and Biochemistry University of Tennessee Health Science Center Memphis TN 38163 USA

Department of Microbiology St George Hospital Sydney NSW 2217 Australia

Emergency Department Royal Perth Hospital Perth WA 6000 Australia

Faculty of Medicine and Health School of Medical Sciences The University of Sydney Sydney NSW 2145 Australia

Faculty of Medicine and Health Sydney Medical School Nepean Nepean Hospital The University of Sydney Kingswood NSW 2747 Australia

Faculty of Medicine and Health Sydney Medical School Westmead Westmead Hospital The University of Sydney Sydney NSW 2145 Australia

Institute of Virology Münster University of Münster 48149 Münster Germany

Medical ICU 1st Department of Internal Medicine Charles University and Teaching Hospital Pilsen 323 00 Plzeň Czech Republic

Medical School University of Western Australia Perth WA 6009 Australia

Research and Education Network Western Sydney Local Health District Westmead Hospital CNR Darcy and Hawkesbury Roads Sydney NSW 2145 Australia

School of Chemistry and Molecular Biosciences The University of Queensland Brisbane QLD 4072 Australia

Sydney Informatics Hub Core Research Facilities The University of Sydney Sydney NSW 2006 Australia

Sydney Institute for Infectious Disease The University of Sydney Sydney NSW 2145 Australia

Victorian Infectious Disease Service The Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity Melbourne VIC 3050 Australia

Westmead Hospital Western Sydney Local Health District Sydney NSW 2145 Australia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004493
003      
CZ-PrNML
005      
20230425141439.0
007      
ta
008      
230418s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms24032524 $2 doi
035    __
$a (PubMed)36768847
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Wang, Ya $u Department of Intensive Care Medicine, Nepean Hospital, Kingswood, NSW 2747, Australia $u Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, Sydney, NSW 2145, Australia $u Faculty of Medicine and Health, Sydney Medical School Nepean, Nepean Hospital, The University of Sydney, Kingswood, NSW 2747, Australia $1 https://orcid.org/0000000202978227
245    10
$a Pathway and Network Analyses Identify Growth Factor Signaling and MMP9 as Potential Mediators of Mitochondrial Dysfunction in Severe COVID-19 / $c Y. Wang, K. Schughart, TM. Pelaia, T. Chew, K. Kim, T. Karvunidis, B. Knippenberg, S. Teoh, AL. Phu, KR. Short, J. Iredell, I. Thevarajan, J. Audsley, S. Macdonald, J. Burcham, . Predict-Consortium, B. Tang, A. McLean, M. Shojaei
520    9_
$a Patients with preexisting metabolic disorders such as diabetes are at a higher risk of developing severe coronavirus disease 2019 (COVID-19). Mitochondrion, the very organelle that controls cellular metabolism, holds the key to understanding disease progression at the cellular level. Our current study aimed to understand how cellular metabolism contributes to COVID-19 outcomes. Metacore pathway enrichment analyses on differentially expressed genes (encoded by both mitochondrial and nuclear deoxyribonucleic acid (DNA)) involved in cellular metabolism, regulation of mitochondrial respiration and organization, and apoptosis, was performed on RNA sequencing (RNASeq) data from blood samples collected from healthy controls and patients with mild/moderate or severe COVID-19. Genes from the enriched pathways were analyzed by network analysis to uncover interactions among them and up- or downstream genes within each pathway. Compared to the mild/moderate COVID-19, the upregulation of a myriad of growth factor and cell cycle signaling pathways, with concomitant downregulation of interferon signaling pathways, were observed in the severe group. Matrix metallopeptidase 9 (MMP9) was found in five of the top 10 upregulated pathways, indicating its potential as therapeutic target against COVID-19. In summary, our data demonstrates aberrant activation of endocrine signaling in severe COVID-19, and its implication in immune and metabolic dysfunction.
650    _2
$a lidé $7 D006801
650    12
$a COVID-19 $7 D000086382
650    _2
$a matrixová metaloproteinasa 9 $x genetika $x metabolismus $7 D020780
650    _2
$a signální transdukce $7 D015398
650    _2
$a mezibuněčné signální peptidy a proteiny $7 D036341
650    _2
$a mitochondrie $x metabolismus $7 D008928
655    _2
$a časopisecké články $7 D016428
700    1_
$a Schughart, Klaus $u Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN 38163, USA $u Institute of Virology Münster, University of Münster, 48149 Münster, Germany $1 https://orcid.org/0000000268247523
700    1_
$a Pelaia, Tiana Maria $u Department of Intensive Care Medicine, Nepean Hospital, Kingswood, NSW 2747, Australia
700    1_
$a Chew, Tracy $u Sydney Informatics Hub, Core Research Facilities, The University of Sydney, Sydney NSW 2006, Australia $1 https://orcid.org/0000000195297705
700    1_
$a Kim, Karan $u Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, Sydney, NSW 2145, Australia
700    1_
$a Karvunidis, Thomas $u Medical ICU, 1st Department of Internal Medicine, Charles University and Teaching Hospital Pilsen, 323 00 Plzeň, Czech Republic
700    1_
$a Knippenberg, Ben $u Department of Microbiology, St. George Hospital, Sydney, NSW 2217, Australia
700    1_
$a Teoh, Sally $u Department of Intensive Care Medicine, Nepean Hospital, Kingswood, NSW 2747, Australia
700    1_
$a Phu, Amy L $u Research and Education Network, Western Sydney Local Health District, Westmead Hospital, CNR Darcy and Hawkesbury Roads, Sydney, NSW 2145, Australia $u Faculty of Medicine and Health, Sydney Medical School Westmead, Westmead Hospital, The University of Sydney, Sydney, NSW 2145, Australia $1 https://orcid.org/0000000237048011
700    1_
$a Short, Kirsty R $u School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia $1 https://orcid.org/0000000349636184
700    1_
$a Iredell, Jonathan $u Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Sydney, NSW 2145, Australia $u Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW 2145, Australia $u Westmead Hospital, Western Sydney Local Health District, Sydney, NSW 2145, Australia $u Sydney Institute for Infectious Disease, The University of Sydney, Sydney, NSW 2145, Australia
700    1_
$a Thevarajan, Irani $u Victorian Infectious Disease Service, The Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3050, Australia $u Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia
700    1_
$a Audsley, Jennifer $u Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia
700    1_
$a Macdonald, Stephen $u Centre for Clinical Research in Emergency Medicine, Harry Perkins Institute of Medical Research, Royal Perth Hospital, Perth, WA 6000, Australia $u Medical School, University of Western Australia, Perth, WA 6009, Australia $u Emergency Department, Royal Perth Hospital, Perth, WA 6000, Australia $1 https://orcid.org/0000000199214620
700    1_
$a Burcham, Jonathon $u Centre for Clinical Research in Emergency Medicine, Royal Perth Bentley Group, Perth, WA 6000, Australia
700    1_
$a Predict-Consortium,
700    1_
$a Tang, Benjamin $u Department of Intensive Care Medicine, Nepean Hospital, Kingswood, NSW 2747, Australia $u Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, Sydney, NSW 2145, Australia
700    1_
$a McLean, Anthony $u Department of Intensive Care Medicine, Nepean Hospital, Kingswood, NSW 2747, Australia $u Faculty of Medicine and Health, Sydney Medical School Nepean, Nepean Hospital, The University of Sydney, Kingswood, NSW 2747, Australia
700    1_
$a Shojaei, Maryam $u Department of Intensive Care Medicine, Nepean Hospital, Kingswood, NSW 2747, Australia $u Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, Sydney, NSW 2145, Australia $u Faculty of Medicine and Health, Sydney Medical School Nepean, Nepean Hospital, The University of Sydney, Kingswood, NSW 2747, Australia
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 24, č. 3 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36768847 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425141435 $b ABA008
999    __
$a ok $b bmc $g 1924913 $s 1190702
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 24 $c 3 $e 20230128 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 5U19A|100625-07 $p NIAID NIH HHS $2 United States
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace